Stockreport

Regeneron and Zai Lab Announce Regional Strategic Collaboration for REGN1979 (CD20xCD3 Bispecific Antibody)

Regeneron Pharmaceuticals, Inc.  (REGN) 
Last regeneron pharmaceuticals, inc. earnings: 2/6 06:30 am Check Earnings Report
US:NASDAQ Investor Relations: investor.regeneron.com
PDF TARRYTOWN, N.Y. and SHANGHAI, April 8, 2020 /PRNewswire/ --Zai Lab obtains rights to develop and exclusively commercialize REGN1979 in oncology in mainland China, Hong K [Read more]